My Blog
Business

JPMorgan upgrades Regeneron, says eye drug launch could help boost shares nearly 20%

JPMorgan upgrades Regeneron, says eye drug launch could help boost shares nearly 20%
JPMorgan upgrades Regeneron, says eye drug launch could help boost shares nearly 20%


Related posts

Microsoft’s Activision talks began after reporting on intercourse misconduct

newsconquest

Taiwan’s Foxconn seeks chip, EV cooperation with India

newsconquest

Disney (DIS) earnings Q1 2023: Bob Iger returns

newsconquest